- Home
- GKOS vs CMA Comparison
GKOS vs CMA Comparison
Compare GKOS & CMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GKOS
- CMA
- Stock Information
- Founded
- GKOS 1998
- CMA 1849
- Country
- GKOS United States
- CMA United States
- Employees
- GKOS N/A
- CMA N/A
- Industry
- GKOS Medical/Dental Instruments
- CMA Major Banks
- Sector
- GKOS Health Care
- CMA Finance
- Exchange
- GKOS Nasdaq
- CMA Nasdaq
- Market Cap
- GKOS 7.4B
- CMA 8.8B
- IPO Year
- GKOS 2015
- CMA N/A
- Fundamental
- Price
- GKOS $145.90
- CMA $64.69
- Analyst Decision
- GKOS Strong Buy
- CMA Hold
- Analyst Count
- GKOS 13
- CMA 24
- Target Price
- GKOS $143.00
- CMA $67.57
- AVG Volume (30 Days)
- GKOS 496.0K
- CMA 2.0M
- Earning Date
- GKOS 11-04-2024
- CMA 01-22-2025
- Dividend Yield
- GKOS N/A
- CMA 4.42%
- EPS Growth
- GKOS N/A
- CMA N/A
- EPS
- GKOS N/A
- CMA 4.01
- Revenue
- GKOS $360,347,000.00
- CMA $3,161,000,000.00
- Revenue This Year
- GKOS $22.68
- CMA N/A
- Revenue Next Year
- GKOS $24.98
- CMA $4.83
- P/E Ratio
- GKOS N/A
- CMA $16.07
- Revenue Growth
- GKOS 18.70
- CMA N/A
- 52 Week Low
- GKOS $74.75
- CMA $45.32
- 52 Week High
- GKOS $147.65
- CMA $73.45
- Technical
- Relative Strength Index (RSI)
- GKOS 58.40
- CMA 35.50
- Support Level
- GKOS $137.60
- CMA $63.88
- Resistance Level
- GKOS $147.50
- CMA $66.77
- Average True Range (ATR)
- GKOS 4.74
- CMA 1.45
- MACD
- GKOS 0.45
- CMA -0.87
- Stochastic Oscillator
- GKOS 87.80
- CMA 9.10
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
About CMA Comerica Incorporated
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.